Arrhythmias & electrophysiology
The HONEST Cohort Study: Rationale and Design of a Nationwide Subcutaneous Implantable Cardioverter-Defibrillator Cohort
Study context
- Population
- All patients who underwent implantation of an subcutaneous implantable cardioverter-defibrillator (S-ICD) (EMBLEM, Boston Scientific) in France between October 2012 and December 201977% males, 49.9 years, 98.2% of all S-ICD implantations during the study period in France
- Participants
- 4,924 patients
Methodological detailsClinical endpoints are centrally adjudicated
- Clinical endpoints are centrally adjudicated
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
The HONEST Cohort Study: Rationale and Design of a Nationwide Subcutaneous Implantable Cardioverter-Defibrillator Cohort. JACC Adv. doi:10.
Summarised from the published abstract; every number is checked against it